Pure Global

Severe Combined Immunodeficiency Disorder (Scid) Newborn Screening Test System

Severe Combined Immunodeficiency Disorder (Scid) Newborn Screening Test System is a medical device type in the Immunology specialty. This page includes real-world medical device registration data worldwide for this device type, with registrations from US FDA, Brazil ANVISA, and other global markets.

View regulatory classifications, recent 510(k) clearances, active device registrations, and similar products registered globally under this device category. Pure Global AI's free directory provides comprehensive worldwide registration intelligence across 7,000+ medical device types and 21 specialties.

Global Registration Data
Multi-Country Intelligence
Severe Combined Immunodeficiency Disorder (Scid) Newborn Screening Test System
Immunology Medical Device Type
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Regulatory Classifications

US Regulatory Classifications

PJI

View Product Code Classification

Class 2

21 CFR 866.5930

View CFR Regulation

Immunology

Device Characteristics

No

No

No

Eligible

Definition

A newborn screening test for severe combined immunodeficiency (SCID) intended for the detection of T-cell receptor excision circle (TREC) genomic DNA isolated from newborn blood specimens dried on filter paper. It is intended as an aid in screening newborns for severe combined immunodeficiency (SCID).